-
Article
Open AccessWhat is Known About Critical Congenital Heart Disease Diagnosis and Management Experiences from the Perspectives of Family and Healthcare Providers? A Systematic Integrative Literature Review
The experience of diagnosis, decision-making and management in critical congenital heart disease is layered with complexity for both families and clinicians. We synthesise the current evidence regarding the fa...
-
Article
Open AccessAntidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
Depressive symptoms are common in patients with Parkinson’s disease and depression is a significant predictor of functional impairment, reduced quality of life and general well-being in Parkinson's disease. De...
-
Chapter
Opportunities Offered by the American College of Surgeons National Surgical Quality Improvement Program (NSQIP)
The American College of Surgeons National Surgical Quality Improvement Program is described briefly, as its use at our organization. Surgeons’ high confidence level in data collected via this program leads to ...
-
Chapter
Engaging the Hospital’s Medical Staff
Engagement of the hospital’s medical staff is a key component of efforts to optimize accuracy of medical record documentation and quality reporting. We identify barriers to understand and education of the medi...
-
Chapter
Perioperative Hemorrhage or Hematoma (AHRQ Patient Safety Indicator 9)
Patient safety indicator (PSI)-9 is one of the most frequently reported PSIs and is a component of the Agency for Healthcare Research and Quality (AHRQ) PSI-90. Knowledge of the documentation triggers for this...
-
Chapter
Postoperative Wound Dehiscence (AHRQ Patient Safety Indicator 14)
Patient safety indicator (PSI)-14 is a component of the Agency for Healthcare Research and Quality (AHRQ) PSI-90 and other safety ratings. Knowledge of the procedural and documentation triggers for this PSI ca...
-
Chapter
Mortality AHRQ Patient Safety Indicators 4 (Failure to Rescue) and 2 (Death in Low Mortality DRGs)
Two AHRQ Patient Safety Indicators (PSI) address in-hospital mortality. PSI-2 calls attention to mortalities that are in low mortality conditions such as birth. PSI-4 attempts to measure how well hospitals do ...
-
Chapter
PSIs of Lesser Frequency: Retained Foreign Items (AHRQ Patient Safety Indicator 5), In-Hospital Falls with Hip Fracture (AHRQ Patient Safety Indicator 8), and Postoperative Kidney Injury Requiring Dialysis (AHRQ Patient Safety Indicator 10)
The three patient safety indicators occur infrequently but are components of several publicly reported ratings and safety risk scores. The relationship to CMS HAC designation is discussed. Knowledge of the doc...
-
Chapter
Patient Safety Indicator-11 (Acute Perioperative Respiratory Failure)
Patient safety indicator (PSI)-11 is one of the four most heavily weighted components of the U S Agency for Healthcare Research and Quality (AHRQ) PSI-90. Knowledge of the documentation and procedural triggers...
-
Chapter
Unrecognized Abdominopelvic Accidental Puncture or Laceration (AHRQ Patient Safety Indicator 15)
Patient safety indicator (PSI)-15 is a component of the Agency for Healthcare Research and Quality (AHRQ) PSI-90 and the Leapfrog Hospital Safety Grade. Knowledge of the documentation and procedural triggers f...
-
Chapter
Postoperative Sepsis (AHRQ Patient Safety Indicator 13)
Patient safety indicator (PSI)-13 is the most heavily weighted component of the US Agency for Healthcare Research and Quality (AHRQ) PSI-90. Knowledge of the documentation and triggers for this PSI can facilit...
-
Article
Cellulose nanofibres from bagasse using a high speed blender and acetylation as a pretreatment
Cellulose nanofibres (CNFs) are attractive as a material because they can be produced on a large scale, they are renewable, biodegradable and have a wide range of applications. The high-speed blender is an eff...
-
Article
The effects of audiovisual distraction on the muscle sympathetic responses to experimental muscle pain
Pain elicited by intramuscular infusion of hypertonic saline solution causes muscle sympathetic nerve activity (MSNA) to increase in some subjects, yet decrease in others. Although the direction of the respons...
-
Article
Open AccessMal de Debarquement Syndrome: a survey on subtypes, misdiagnoses, onset and associated psychological features
Mal de Debarquement Syndrome (MdDS) is a neurological condition typically characterized by a sensation of motion, that persists longer than a month following exposure to passive motion (e.g., cruise, flight, e...
-
Article
Immune-mediated cytopenia in pediatric primary immune deficiency patients following HSCT
-
Article
Assessing the current state of cognitive frailty: Measurement properties
Currently, an estimated 25-30% of people ages 85 or older have dementia, with a projected 115 million people worldwide living with dementia by 2050. With this worldwide phenomenon fast approaching, early detec...
-
Chapter
Waldenstrom’s Macroglobulinaemia: Immunosurveillance and the Immune Micro-environment
Understanding the interactions of the immune system and B-cell tumours has great therapeutic potential. Both in myeloma and Waldenstrom’s macroglobulinaemia (WM), there are measurable changes in the immune sys...
-
Article
Time history of diesel particle deposition in cylindrical dielectric barrier discharge reactors
Non-thermal plasma (NTP) treatment reactors have recently been developed for elimination of diesel particulate matter for reducing both the mass and number concentration of particles. The role of the plasma it...
-
Article
Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade
Tumour-induced dysfunction of cytotoxic T cells in patients with multiple myeloma (MM) may contribute to immune escape and be responsible for the lack of therapeutic efficacy of immune checkpoint blockade. We ...
-
Article
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial
Carboplatin/taxane combination is first-line therapy for ovarian cancer. However, patients can encounter treatment delays, impaired quality of life, even death because of chemotherapy-induced gastrointestinal ...
